Menu
Not yet recruiting NCT06945133

Correlation Study Between the Classification of Arthrogenic Motor Inhibition (AMI) and Clinical Assessment After ACL Rupture

No phase Interventional ACL - Anterior Cruciate Ligament Rupture

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Clinical testing.
Who it may be relevant to
Registry conditions: ACL - Anterior Cruciate Ligament Rupture. Basic parameters: 18 years — 44 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this interventional study is to measure medial vastus inhibition and associate it with AMI classification in patients with ACL rupture. The main question it aims to answer is: Is there a correlation between AMI classification and clinical assessment after ACL rupture ? Participants will undergo surface EMG and Myotonometry.

Interventions

  • Other Clinical testing
    Intervention includes : * Surface EMG to measure inhibition of the VM and the rectus femoris (RF) on the injured and non-injured sides during attempts at voluntary contractions of the knee extensor muscles. * Myotonometry to measure the stiffness of the semimembranosus and biceps femoris (long head) on the injured and non-injured sides under resting conditions

Primary outcome measures

  • Muscle Surface EMG and AMI correlation [Time frame: From enrollment to Day 30]

Eligibility criteria

Inclusion criteria

  • Patient, male or female, aged ≥ 18 years and < 45 years
  • Patient with an ACL rupture confirmed by MRI
  • Patient with an ACL rupture ≤ 30 days old
  • French speaking patient who does not object to the use of his/her data

Exclusion criteria

  • Patient with previous ipsi or contralateral knee injury/surgery
  • Patient with multi-ligament injury
  • Pregnant or breastfeeding woman

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Basic science

Study locations

France · 1 center
  • Hôpital Privé Jean Mermoz — Lyon

Identifiers

NCT: NCT06945133 · 2025-A00125-44 · 2025-A00125-44

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗